市場調查報告書
商品編碼
1521231
2024-2032 年按產品(發電機、儀器、配件)、應用(普通外科、腹腔鏡手術)、最終用戶(醫院和專科診所、門診手術中心)和地區分類的血管密封裝置市場報告Vessel Sealing Devices Market Report by Product (Generators, Instruments, Accessories), Application (General Surgery, Laparoscopic Surgery), End User (Hospitals and Specialty Clinics, Ambulatory Surgical Centers), and Region 2024-2032 |
IMARC Group年,全球容器密封裝置市場規模達到19億美元。
血管封閉裝置是指在非侵入性外科手術中使用的器械,以方便開腹和腹腔鏡手術中的解剖和止血。電熱雙極容器密封器和超音波剪切機是一些常用的容器密封裝置。它們由超音波、雙極和混合能量組成,有助於凝固、切割和解剖應用。血管封閉裝置廣泛用於透過使管壁中的膠原蛋白和彈性蛋白變性並完全閉塞血管來封閉血管壁。這些設備易於使用,需要更少的操作時間,有助於減少失血,提供卓越的效率和可靠性,並且具有成本效益。因此,血管封閉裝置廣泛應用於專科診所、醫院和門診手術中心。
更容易患慢性病的老年人口不斷增加是創造積極市場前景的關鍵因素之一。血管封閉裝置廣泛用於治療大腸直腸癌、頸部手術、腋窩淋巴結清除及慢性肝炎等。此外,腹腔鏡手術中產品的廣泛採用,因為它們是微創且術後疼痛較少,有利於市場成長。除此之外,監測熱量和能量分佈的超音波技術以及有助於更強和均勻壓縮的雙極設備的引入也為市場成長提供了推動力。此外,手術期間對安全有效的器械以降低感染率和失血量的需求不斷增加,導致醫療密封設備的整體銷售增加,從而對市場成長產生積極影響。其他因素,包括新型、高品質血管密封裝置的開發、婦科、泌尿科、心血管和骨科手術數量的增加,以及醫療行業的顯著擴張,預計將推動市場成長。
The global vessel sealing devices market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032.
Vessel sealing devices refer to instruments used in non-invasive surgical procedures to facilitate dissection and hemostasis during open and laparoscopic procedures. Electrothermal bipolar vessel sealers and ultrasonic shears are some of the commonly used vessel sealing devices. They consist of ultrasonic, bipolar and hybrid energies and are helpful in coagulation, cutting and dissection applications. Vessel sealing devices are widely used to seal the vessel wall by denaturing the collagen and elastin in the wall and completely occluding the blood vessel. These devices are easy to use, require less operational time, assist in reducing blood loss, offer superior efficiency and reliability, and are cost-effective. As a result, vessel sealing devices are widely used in specialty clinics, hospitals and ambulatory surgical centers.
The increasing geriatric population that is more prone to chronic diseases is one of the key factors creating a positive outlook for the market. Vessel sealing devices are widely used to treat colorectal cancer, neck surgery, axillary dissection, and chronic hepatitis, amongst others. Additionally, the widespread product adoption in laparoscopic surgeries as they are minimally invasive and cause less postoperative pain, is favoring the market growth. Apart from this, the introduction of ultrasound technology that monitors the distribution of heat and energy and bipolar devices that assist in stronger and uniform compression, are also providing a thrust to the market growth. Moreover, the increasing demand for safe and effective instruments during surgeries to reduce infection rates and blood loss is inflating the overall sales of medical sealing devices, thus positively impacting the market growth. Other factors, including the development of novel, high-quality vessel sealing devices, a rise in the number of gynecological, urological, cardiovascular and orthopedic surgeries, and significant expansion in the medical industry, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global vessel sealing devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.
Generators
Instruments
Accessories
General Surgery
Laparoscopic Surgery
Hospitals and Specialty Clinics
Ambulatory Surgical Centers
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, BOWA-electronic GmbH & Co. KG, Erbe Elektromedizin GmbH, Hologic Inc., Intuitive Surgical Inc., Johnson & Johnson, KLS Martin Group, Lamidey Noury Medical, Medtronic plc, Olympus Corporation, OmniGuide Holdings Inc. and Xcellance Medical Technologies Private Limited.